Practical considerations in the delivery of genetic counseling and testing services for inherited cancer predisposition

Community Oncology

Volumn 10, Issue 5, 2013, Pages 147-153

  Pal, Tuya ^a   Radford, Cristi ^a   Vadaparampil, Susan ^a   Prince, Anya ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Cancer Legal Resource Center Disability Rights Legal Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETIC RISK ASSESSMENT SERVICE; CANCER GENETICS; CANCER PATIENT; CANCER PREVENTION; CANCER SCREENING; CANCER SURGERY; CANCER SUSCEPTIBILITY; CANCER THERAPY; CLINICAL LABORATORY; COMMUNITY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FAMILIAL CANCER; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GENETIC COUNSELING; GENETIC SCREENING; GENOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH SERVICE; HUMAN; LAW; LICENSING; LONG TERM CARE; MALPRACTICE; MEDICAL EDUCATION; PATIENT CARE; PERSONALIZED MEDICINE; PROFESSIONAL KNOWLEDGE; REIMBURSEMENT; RISK ASSESSMENT; UNITED STATES;

EID: 84900318158     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.12788/j.cmonc.0010     Document Type: Article

References (61)

1. Radford C. Understanding the Evolution of and Term "Genetic Counselor": is the Term Being Used Appropriately in Your Community. The Oncology Nurse. 2011;4(5): 24-25.
2. Weitzel JN, Blazer KR, Macdonald DJ, Culver JO, Offit K. Genetics, genomics, and cancer risk assessment: state of the art and future directions in the era of personalized medicine. CA Cancer J Clin. [Epub ahead of print].
3. Fraser FC. Genetic counseling. Am J Hum Genet. 1974;26(5): 636-661.
4. Bernhardt BA, Biesecker BB, Mastromarino CL. Goals, benefits, and outcomes of genetic counseling: client and genetic counselor assessment. Am J Med Genet. 2000;94(3): 189-197.
5. Shiloh S, Avdor O, Goodman RM. Satisfaction with genetic counseling: dimensions and measurement. Am J Med Genet. 1990; 37(4): 522-529.
6. Pilnick A, Dingwall R. Research directions in genetic counselling: a review of the literature. Patient Educ Couns. 2001;44(2): 95-105.
7. MacDonald DJ, Blazer KR, Weitzel JN. Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: the power of partnership. J Natl Compr Canc Netw. 2010;8(5): 615-624.
8. Zon RT, Goss E, Vogel VG, et al. American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment. J Clin Oncol. 2009;27(6): 986-993.
9. Geier LJ, Mulvey TM, Weitzel JN. Clinical cancer genetics remains a specialized area: how do I get there from here? ASCO 2009 Educational Book: Practice Management and Information Technology. http://meetinglibrary.asco.org/ sites/meetinglibrary.asco.org/files/Educational%20Book/PDF%20Files/2009/09edbk. practmgmt. 03.pdf. Accessed April 26, 2013.
10. Evans JP. Health care in the age of genetic medicine. JAMA. 2007;298(22): 2670-2672.
11. ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome. Obstet Gynecol. 2009;113(4): 957-966.
12. Bowen DJ, Battuello KM, Raats M. Marketing genetic tests: empowerment or snake oil? Health Educ Behav. 2005;32(5): 676-685.
13. Vadaparampil ST, Wideroff L, Breen N, Trapido E. The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2006;15(4): 618-623.
14. Hogarth S, Javitt G, Melzer D. The current landscape for directto- consumer genetic testing: legal, ethical, and policy issues. Annu Rev Genomics Hum Genet. 2008;9: 161-182.
15. Javitt GH, Hudson K. Federal Neglect: Regulation of Genetic Testing. Issues in Science and Technology. 2006;22(3): 59-66.
16. Horn EJ, Terry SF. Regulating genetic tests: issues that guide policy decisions. Genet Test Mol Biomarkers. 2012;16(1): 1-2.
17. ACLU Challenges Patents on Breast Cancer Genes: BRCA [news release]. American Civil Liberties Union. Released May 12, 2009, updated May 15, 2009. http://www.aclu.org/free-speechwomens- rights/aclu-challenges-patents-breast- cancer-genes. Accessed June 22, 2012.
18. Huys I, Matthijs G, Van Overwalle G. The fate and future of patents on human genes and genetic diagnostic methods. Nat Rev Genet. 2012;13(6): 441-448.
19. Association for Molecular Pathology v. Myriad Genetics [news release]. American Civil Liberties Union. http://www.aclu.org/print/free-speechtechnology- and-liberty-womens-rights/association-molecularpathology- v-myriad-genetics. Released April 14, 2013. Accessed April 26, 2013.
20. DeMarco TA, Smith KL, Nusbaum RH, Peshkin BN, Schwartz MD, Isaacs C. Practical aspects of delivering hereditary cancer risk counseling. Semin Oncol. 2007;34(5): 369-378.
21. Lawrence WF, Peshkin BN, Liang W, Isaacs C, Lerman C, Mandelblatt JS. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations. Cancer Epidemiol Biomarkers Prev. 2001;10(5): 475-481.
22. Schwartz GF, Hughes KS, Lynch HT, et al. Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Breast J. 2009;15(1): 4-16.
23. Hampel H, Sweet K, Westman JA, Offit K, Eng C. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet. 2004;41(2): 81-91.
24. Weitzel JN. Genetic cancer risk assessment. Putting it all together. Cancer. 1999;86(11 Suppl): 2483-2492.
25. Ganz PA, Kwan L, Somerfield MR, et al. The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members. J Clin Oncol. 2006;24(18): 2948-2957.
26. McPherson E, Zaleski C, Benishek K, et al. Clinical genetics provider real-time workflow study. Genet Med. 2008;10(9): 699-706.
27. Tung N. Management of women with BRCA mutations: a 41- year-old woman with a BRCA mutation and a recent history of breast cancer. JAMA. 2011;305(21): 2211-2220.
28. Bernhardt BA, Tumpson JE, Pyeritz RE. The economics of clinical genetics services. IV. Financial impact of outpatient genetic services on an academic institution. Am J Hum Genet. 1992;50(1): 84-91.
29. National Society of Genetic Counselors. States issuing licenses for genetic counselors. http://www.nsgc.org/Advocacy/StatesIssuingLicensesfor- GeneticCounselors/tabid/347/Default.aspx. Updated September 18, 2012. Accessed June 15, 2012.
30. Plon SE, Cooper HP, Parks B, et al. Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genet Med. 2011;13(2): 148-154.
31. PriorityHealth. Counseling before genetic testing. http://www. priorityhealth.com/member/health-wellness/health-help/geneticcounseling. Updated December 12, 2012. Accessed June 15, 2012.
32. Duquette D, Lewis K, McLosky J, Bach J. Using core public health functions to promote BRCA best practices among health plans. Public Health Genomics. 2012;15(2): 92-97.
33. Preventive Services Covered Under the Affordable Care Act. Healthcare. gov Web site. http://www.healthcare.gov/news/factsheets/2010/07/preventive- services-list.html. Updated September 27, 2012. Accessed June 22, 2012.
34. Acheson LS, Stange KC, Zyzanski S. Clinical genetics issues encountered by family physicians. Genet Med. 2005;7(7): 501-508.
35. Vig HS, Armstrong J, Egleston BL, et al. Cancer genetic risk assessment and referral patterns in primary care. Genet Test Mol Biomarkers. 2009;13(6): 735-741.
36. O'Neill SC, Peshkin BN, Luta G, Abraham A, Walker LR, Tercyak KP. Primary care providers' willingness to recommend BRCA1/2 testing to adolescents. Fam Cancer. 2010;9(1): 43-50.
37. Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23(2): 276-292.
38. Brierley KL, Blouch E, Cogswell W, et al. Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications. Cancer J. 2012;18(4): 303-309.
39. Brierley KL, Campfield D, Ducaine W, et al. Errors in delivery of cancer genetics services: implications for practice. Conn Med. 2010;74(7): 413-423.
40. Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2010;28(5): 893-901.
41. Esserman L, Kaklamani V. Lessons learned from genetic testing. JAMA. 2010;304(9): 1011-1012.
42. Caleshu C, Day S, Rehm HL, Baxter S. Use and interpretation of genetic tests in cardiovascular genetics. Heart. 2010;96(20): 1669-1675.
43. Cohen SA, McIlvried D, Schnieders J. A Collaborative Approach to Genetic Testing: A Community Hospital's Experience. J Genet Couns. 2009;18(6): 530-533.
44. Easton DF, Deffenbaugh AM, Pruss D, et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet. 2007;81(5): 873-883.
45. Integrating genetic risk assessment into practice. J Onc Prac. 2008; 4(5): 214-219
46. Lindor RA, Marchant GE. A review of medical malpractice claims related to clinical genetic testing [ASCO abstract 6073]. J Clin Onc. 2011;29(suppl)
47. Marchant GE, Campos-Outcalt DE, Lindor RA. Physician liability: the next big thing for personalized medicine? Personalized Medicine. 2011;8(4): 457-467.
48. (ASCO) ASoCO. Cancer Genetics and Cancer Predisposition Testing. 2nd ed. Alexandria, VA: American Society of Clinical Oncology Publishing; 2004.
49. Daly MB, Axilbund JE, Buys S, et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2010; 8: 562-594.
50. Calzone KA, Jenkins J, Masny A. Core competencies in cancer genetics for advanced practice oncology nurses. Oncol Nurs Forum. 2002;29: 1327-1333.
51. Genetic testing in adoption. The American Society of Human Genetics Social Issues Committee and The American College of Medical Genetics Social, Ethical, and Legal Issues Committee. Am J Hum Genet. 2000;66: 761-767.
52. Kolb SE, Aguilar MC, Dinenberg M, Kaye CI. Genetics education for primary care providers in community health settings. J Community Health. 1999;24: 45-59.
53. Korf BR. Medical education in the 'postgenomic era.' Postgrad Med. 2000;108: 15-18.
54. Peterson SK, Rieger PT, Marani SK, deMoor C, Gritz ER. Oncology nurses' knowledge, practice, and educational needs regarding cancer genetics. Am J Med Genet. 2001;98: 3-12.
55. Reynolds PP, Benkendorf JL. Genes and generalists: why we need professionals with added competencies. West J Med. 1999;171: 375-379.
56. Schwartz MD, Valdimarsdottir HB, DeMarco TA, et al. Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychol. 2009;28: 11-19.
57. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. 1997;336: 823-827.
58. Wilkins-Haug L, Erickson K, Hill L, Power M, Holzman GB, Schulkin J. Obstetrician-gynecologists' opinions and attitudes on the role of genetics in women's health. J Womens Health Gend Based Med. 2000;9: 873-879.
59. Baars MJ, Henneman L, Ten Kate LP. Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genet Med. 2005;7: 605-610.
60. Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005;42: 749-755.
61. Grosse SD, Khoury MJ. What is the clinical utility of genetic testing? Genet Med. 2006;8: 448-450.